Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Ethosomal carriers effectively deliver hair loss drug into skin.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

New microneedles deliver drugs through the skin accurately and effectively.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Sunlight exposure increases drug toxicity; amber glass best for protection.

Moving horses to new places can increase their stress levels, as shown by higher stress hormone in their hair.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.